Pharmazeutisch
Braftovi-H-C-4280-WS-2538 EPAR - Assessment report - Variation
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Braftovi-H-C-4280-WS-2538 EPAR - Assessment report - Variation
Stärke
Braftovi-H-C-4280-WS-2538 EPAR - Assessment report - Variation
Packungsgröße
Braftovi-H-C-4280-WS-2538 EPAR - Assessment report - Variation
Form
Braftovi-H-C-4280-WS-2538 EPAR - Assessment report - Variation
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Braftovi-H-C-4280-WS-2538 EPAR - Assessment report - Variation
Nebenwirkungen
Braftovi-H-C-4280-WS-2538 EPAR - Assessment report - Variation